In the latest trading session,, 7.01 million Insmed Inc (NASDAQ:INSM) shares changed hands as the company’s beta touched 0.79. With the company’s most recent per share price at $89.80 changing hands around $19.12 or 27.05% at last look, the market valuation stands at $16.36B. INSM’s last price was a premium, traded about 5.45% off its 52-week high of $84.91. The share price had its 52-week low at $56.03, which suggests the last value was 37.61% up since then. When we look at Insmed Inc’s average trading volume, we note the 10-day average is 2.51 million shares, with the 3-month average coming to 2.29 million.
Analysts gave the Insmed Inc (INSM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.05. If we narrow down to specifics, the data shows that 1 out of 14 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended INSM as a Hold, 13 felt it is a Buy and 0 rated the stock as Underweight.
Insmed Inc (NASDAQ:INSM) trade information
Instantly INSM is in green as seen in intraday trades today. With action 22.88%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 30.07%, with the 5-day performance at 22.88% in the green. However, in the 30-day time frame, Insmed Inc (NASDAQ:INSM) is 37.98% up. Looking at the short shares, we see there were 16.47 million shares sold at short interest cover period of 6.4 days.
The consensus price target for the stock as assigned by Wall Street analysts is 110, meaning bulls need an upside of 18.36% from its recent market value. According to analyst projections, INSM’s forecast low is 110 with 110 as the target high. To hit the forecast high, the stock’s price needs a -22.49% plunge from its current level, while the stock would need to soar -22.49% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -13.12%. The 2025 estimates are for Insmed Inc earnings to increase by 6.01%, but the outlook for the next 5-year period is at 47.10% per year.
INSM Dividends
Insmed Inc is expected to release its next quarterly earnings report on 2025-May-07.
Insmed Inc (NASDAQ:INSM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.81% of Insmed Inc shares while 115.68% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 116.63%. There are 115.68% institutions holding the Insmed Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 10.3509% of the shares, roughly 16.01 million INSM shares worth $1.07 billion.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 9.2206% or 14.26 million shares worth $955.72 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and T. Rowe Price New Horizons Fund, Inc. . With 5.73 shares estimated at $513.58 million under it, the former controlled 3.14% of total outstanding shares. On the other hand, T. Rowe Price New Horizons Fund, Inc. held about 2.53% of the shares, roughly 4.61 shares worth around $413.55 million.
